Target intelligence / Profile preview

Major Histocompatibility Complex Class I and II Antigen Presentation Machinery (MHC I/II APM)

Target
MHC I/II APM
Molecular classification
Receptor, Transporter, Enzyme, Other
01

Overview

The Major Histocompatibility Complex (MHC) class I and II antigen presentation machinery is a coordinated cellular system responsible for processing intracellular and extracellular proteins into peptide fragments and displaying them on the cell surface. This machinery is fundamental to adaptive immunity, enabling CD8+ cytotoxic T cells and CD4+ helper T cells to survey the proteome for signs of infection, malignancy, or foreign grafts. Key components of this pathway include the immunoproteasome, the Transporter associated with Antigen Processing (TAP), and the peptide-loading complex.

In oncology, many tumors downregulate or mutate components of this machinery to evade immune detection, contributing to resistance against immune checkpoint inhibitors. Conversely, therapeutic strategies aim to restore or enhance its function using epigenetic modulators (such as HDAC or EZH2 inhibitors) or small molecules (like harmine derivatives) to increase tumor immunogenicity. In transplantation medicine, ex vivo gene therapies (such as ALG-115) are being developed to selectively downregulate this machinery in donor organs, reducing graft immunogenicity and preventing rejection without requiring lifelong systemic immunosuppression.

Other names
MHC class I and II antigen presentation pathwayMHC I/II antigen presentationAntigen processing and presentation machineryAntigen presentation machineryAPMTumor-associated antigen presentationHLA antigen presentation
02

Mechanism of action

Modulation of antigen presentation through epigenetic upregulation (e.g., HDAC or EZH2 inhibition), proteasomal inhibition, or ex vivo gene silencing to alter the cell-surface expression of peptide-MHC complexes.

03

Biological functions

Antigen processingAntigen presentationT cell activationImmune surveillanceAdaptive immunityImmune responseProtein degradationProtein transport
04

Disease associations

CancerInfectionAutoimmune diseaseInflammationOther
05

Safety considerations

Risk of autoimmunity due to increased presentation of self-antigensSystemic toxicity associated with epigenetic modulatorsPotential for cytokine release syndrome (CRS)Acquired resistance through structural loss of MHC genes (e.g., B2M deletion)Vulnerability of MHC-silenced cells to natural killer (NK) cell-mediated attack
06

Interacting drugs

10 more in the full profile.

07

Biomarkers

MHC Class I expression levelMHC Class II expression levelBeta-2 microglobulin (B2M) expressionTAP1/TAP2 expression levelsHLA-DR expressionTumor mutational burden (TMB)Neoantigen loadCD8+ T cell infiltration

Beyond the preview

Go deeper on Major Histocompatibility Complex Class I and II Antigen Presentation Machinery (MHC I/II APM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Major Histocompatibility Complex Class I and II Antigen Presentation Machinery (MHC I/II APM).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call